BURLINGTON, Mass., May 20, 2014 /PRNewswire/ -- Decision Resources Group (DRG), one of the world's leading firms focusing on healthcare insights, data and analytics, and services, today announced that it has signed a strategic channel alliance agreement with Activate Networks, Inc. This expands on a multi-year research collaboration between the two companies and will allow Decision Resources Group to incorporate Activate Networks' proprietary Network Mapping and Physician Influence modeling capabilities into both its expanded Data and Decision Science team and its market-leading analytic solutions for pharmaceutical, medical device and managed care clients.

This combination will create the capability, previously unavailable in the life sciences industry, to provide accurate intelligence on which physicians to target for brand launch or ongoing competitive situations. Until now, physician targeting has been based on relatively basic measures such as prescription volume and basic analysis of claims data. This new capability is faster, more accurate and allows for more effective use of resources when launching new products in an increasingly competitive environment.

The alliance will further extend the capabilities of the Decision Resources Group Data and Decision Science team, which provides unified data integration solutions, predictive modeling, and "So What?" analytics to pharmaceutical, medical device, managed care and other life sciences clients. Specialized in life sciences and healthcare, the DRG Data and Decision Science team brings a unique, industry-specific decision support capability to leaders across these industries who are struggling to effectively make data-driven decisions.

"Combining Activate Networks' unique Physician Influence modeling with our formulary, managed care, epidemiology, disease state and pipeline data and analytics provides a complete view of treatment adoption influences and patterns," said Courtney Morris, Executive Vice President of Solutions for Decision Resources Group. "It will provide biopharma and medtech brand and sales operations teams with an unprecedented view of how and why their treatments are adopted, and give them the tools needed to influence the speed of that adoption."

Activate Networks uses proprietary technology, based on patented and patent-pending knowledge from Harvard University, to improve uptake across the brand lifecycle, from pre-launch through brand maturity.  By understanding both individual and network characteristics of prescribers, Activate Networks has demonstrated improved targeting leading to dramatically increased sales, as well as increased promotional efficiency.

"We've worked with Decision Resources Group for more than a year to create a comprehensive data asset addressing the critical factors that inform brand decisions," said Lawrence Miller, CEO of Activate Networks. "The result is unmatched predictive power for brand managers. This approach will enable these managers to implement, monitor and adjust effective strategies."

About Decision Resources Group
Decision Resources Group offers best-in-class, high-value information and insights on critical issues within the healthcare industry. Clients rely on this analysis and data to make informed decisions. Find out more at www.DecisionResourcesGroup.com.

About Activate Networks, Inc.
Activate Networks, Inc. is the leading provider of network analytics for healthcare/life sciences companies, identifying the key connections that drive commercial success. Activate Networks' analytics platform and suite of SaaS software applications enable healthcare/life sciences companies to unlock the commercial value of their customer networks.

Activate Networks' analytics platform is based on groundbreaking social-science research by Prof. Nicholas Christakis of Yale University and colleagues. More information can be found at www.activatenetworks.net.

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.

For more information, contact:

Elizabeth Marshall
Decision Resources Group
781-993-2563
emarshall@dresourcesgroup.com

Logo - http://photos.prnewswire.com/prnh/20130103/MM36768LOGO

SOURCE Decision Resources Group

While Gilead's Sovaldi Continues to Dominate the Hepatitis C Space, Janssen's Olysio Has Gained Market Share Driven by Off-label Prescribing

View Now